Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marta Panz-Klapuch"'
Autor:
Florent Malard, Michael Loschi, Anne Huynh, Thomas Cluzeau, Sarah Guenounou, Faezeh Legrand, Leonardo Magro, Corentin Orvain, Amandine Charbonnier, Marta Panz-Klapuch, Deborah Desmier, Jean-Baptiste Mear, Jérôme Cornillon, Christine Robin, Etienne Daguindau, Karin Bilger, Maria J.G.T. Vehreschild, Patrice Chevallier, Hélène Labussière-Wallet, Clémence Mediavilla, Marie-Anne Couturier, Claude-Eric Bulabois, Vincent Camus, Sylvain Chantepie, Patrice Ceballos, Béatrice Gaugler, Ernst Holler, Joël Doré, Emmanuel Prestat, Cyrielle Gasc, Emilie Plantamura, Mohamad Mohty
Publikováno v:
EClinicalMedicine, Vol 62, Iss , Pp 102111- (2023)
Summary: Background: Failure of gastrointestinal acute graft-versus-host disease (GI-aGvHD) to respond to steroid therapy is associated with limited further therapeutic options. We aimed to assess the safety and efficacy of the first-in-human use of
Externí odkaz:
https://doaj.org/article/358931ad3a1e470aadcd16ab7663faaf
Autor:
Adrianna Spałek, Iwona Grygoruk-Wiśniowska, Karolina Gruenpeter, Marta Panz-Klapuch, Grzegorz Helbig
Publikováno v:
Medicina, Vol 58, Iss 12, p 1722 (2022)
Chronic graft-versus-host disease (cGVHD) is a serious complication after allogenic hematopoietic stem cell transplantation (allo-HSCT), negatively affecting the morbidity and mortality of recipients. Skin involvement is the most common cGVHD manifes
Externí odkaz:
https://doaj.org/article/9b7a7942dd8846ef9f74fdba43f78964
Autor:
Agata Wieczorkiewicz-Kabut, Anna Koclęga, Anna Armatys, Marta Panz-Klapuch, Dariusz Kata, Krzysztof Wozniczka, Grzegorz Helbig, Anna Kopińska
Publikováno v:
Neoplasma. 67:1431-1436
High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (ASCT) remains a valuable therapeutic approach for relapsed and refractory (R/R) patients with diffuse large B-cell lymphoma (DLBCL). The aim of the study was to ev
Autor:
Marta, Panz-Klapuch, Adrianna, Spałek, Katarzyna, Duda, Anna, Kopińska, Agata, Wieczorkiewicz-Kabut, Grzegorz, Helbig
Publikováno v:
Polish archives of internal medicine. 132(3)
Autor:
Marta Panz-Klapuch, Adrianna Spałek, Katarzyna Duda, Anna Kopińska, Agata Wieczorkiewicz-Kabut, Grzegorz Helbig
Publikováno v:
Polish Archives of Internal Medicine.
Autor:
Anna Kopińska, Marta Panz-Klapuch, Anna Koclęga, Grzegorz Helbig, Kinga Boral, Krzysztof Woźniczka, Iwona Grygoruk-Wiśniowska
Publikováno v:
Acta Haematologica Polonica. 51:51-55
IntroductionSystemic mastocytosis (SM) with an associated hematological neoplasm (SM-AHN) constitutes about 40% of all patients with SM. AHN commonly includes myeloid neoplasms and chronic myelomonocytic leukemia (CMML) is seen in about 30% of these
Autor:
Martyna Dworaczek, Marta Panz-Klapuch, Kinga Boral, Miroslaw Markiewicz, Anna Armatys, Anna Koclęga, Krzysztof Woźniczka, Anna Kopińska, Grzegorz Helbig, Karolina Chromik
Publikováno v:
Pathology Oncology Research
The administration of azacitidine (AZA) was found to be more effective than conventional care regimen (CCR) in patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML) with low
Autor:
Hélène Lanic, Angela Granata, Caroline Le Jeune, Corentin Orvain, Delphine Martineau, Anne Huynh, Hélène Labussière-Wallet, Maria J G T Vehreschild, Ernst Holler, Michael Loschi, Claude-Eric Bulabois, Vincent Camus, Raynier Devillier, Mohamad Mohty, Cécile Borel, Amandine Le Bourgeois, Faezeh Legrand, Amandine Charbonnier, Deborah Desmier, Marie-Anne Couturier, Karin Bilger, Emilie Plantamura, Sarah Guenounou, Valerio Maisano, Etienne Daguindau, Patrice Ceballos, Mirosław Markiewicz, Cyrielle Gasc, Jérôme Cornillon, Faustine Lhomme, Patrice Chevallier, Sylvain Chantepie, Marta Panz-Klapuch, Florent Malard, Thomas Cluzeau, Leonardo Magro, Jean-Baptiste Mear, Christine Robin, Niels Moya
Publikováno v:
Blood. 138:262-262
Introduction Failure to respond to steroid therapy for intestinal acute graft-versus-host disease (aGvHD) is associated with limited further therapeutic options. Fecal microbiotherapy is defined as the perfusion of treated stool from one or several h
Autor:
Anna Kopińska, Krzysztof Wozniczka, Grzegorz Helbig, M Dworaczek, Karolina Chromik, Anna Armatys, A Janikowska, Anna Koclęga, M Wysocka, Kinga Boral, Marta Panz-Klapuch
Publikováno v:
Neoplasma. 65(6)
The incorporation of pegylated asparaginase (PEG-ASP) in pediatric and adult acute lymphoblastic leukemia (ALL) protocols remains a worldwide therapeutic approach. However the safety profile remains a challenge, and herein we report the toxicity of a